Skip to main content
Clinical Trials/ISRCTN15790927
ISRCTN15790927
Completed
未知

se of telemedical models and devices in the home management of type 2 diabetes mellitus to improve diabetic control - measured as blood sugar and glycated hemoglobin levels - and the patients' perceived quality of life

GPI SpA0 sites161 target enrollmentJanuary 25, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 Diabetes Mellitus (T2DM)
Sponsor
GPI SpA
Enrollment
161
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2021 Results article in https://dx.doi.org/10.4103/VIT-1 (added 21/09/2021)

Registry
who.int
Start Date
January 25, 2019
End Date
May 31, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
GPI SpA

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with type 2 diabetes mellitus (T2DM)
  • 2\. Diagnosis of DM made at least 1 year before the start of the study
  • 3\. Hypoglycemic treatment remained the same in the 3 months preceding the start of the study

Exclusion Criteria

  • 1\. Diabetes other than T2DM
  • 2\. Pregnant women
  • 3\. Chronic conditions other than T2DM
  • 4\. Unable to give informed consent
  • 5\. Dementia or psychiatric conditions that can affect a person's will or ability to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials